235 related articles for article (PubMed ID: 34485127)
1. Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment.
Zhang X; Fu Y; Ding Z; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
Front Oncol; 2021; 11():692390. PubMed ID: 34485127
[TBL] [Abstract][Full Text] [Related]
2. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint.
Ding Z; He Y; Fu Y; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
Front Oncol; 2021; 11():687430. PubMed ID: 34211854
[TBL] [Abstract][Full Text] [Related]
3. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.
Li J; Chen S; Liao Y; Wang H; Zhou D; Zhang B
Front Oncol; 2022; 12():925743. PubMed ID: 35875097
[TBL] [Abstract][Full Text] [Related]
4. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.
Hu X; Dong Y; Xie S; Song Y; Yu C; He Y; Wang Z; Hu Q; Ni Y; Ding L
J Pathol Clin Res; 2024 Mar; 10(2):e353. PubMed ID: 38502058
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.
Zhu N; Ding L; Fu Y; Yang Y; Chen S; Chen W; Zhao M; Zhao X; Lu Z; Ni Y; Hu Q
J Oral Pathol Med; 2020 Feb; 49(2):126-136. PubMed ID: 31660637
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
11. Lipid Droplet-Related PLIN2 in CD68
He Y; Dong Y; Zhang X; Ding Z; Song Y; Huang X; Chen S; Wang Z; Ni Y; Ding L
Front Oncol; 2022; 12():824235. PubMed ID: 35372038
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
13. Diminished CD68
Zhao X; Ding L; Lu Z; Huang X; Jing Y; Yang Y; Chen S; Hu Q; Ni Y
Am J Pathol; 2020 Apr; 190(4):886-899. PubMed ID: 32035062
[TBL] [Abstract][Full Text] [Related]
14. ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study.
Dong Y; Hu X; Xie S; Song Y; He Y; Jin W; Ni Y; Wang Z; Ding L
Front Cell Dev Biol; 2023; 11():1257314. PubMed ID: 37842091
[No Abstract] [Full Text] [Related]
15. ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma.
Sekiguchi S; Yorozu A; Okazaki F; Niinuma T; Takasawa A; Yamamoto E; Kitajima H; Kubo T; Hatanaka Y; Nishiyama K; Ogi K; Dehari H; Kondo A; Kurose M; Obata K; Kakiuchi A; Kai M; Hirohashi Y; Torigoe T; Kojima T; Osanai M; Takano K; Miyazaki A; Suzuki H
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686580
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer.
Arebro J; Towle R; Lee CM; Bennewith KL; Garnis C
Front Cell Dev Biol; 2023; 11():1240159. PubMed ID: 37745296
[No Abstract] [Full Text] [Related]
17. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
18. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
20. CD8
Zhang Y; Li L; Zheng W; Zhang L; Yao N
Ann Transl Med; 2022 Mar; 10(6):273. PubMed ID: 35434003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
